Innovation alone cannot transform healthcare. Without the right conditions, even the most promising ideas struggle to reach clinical use. As Europe moves forward with the European Health Data Space (EHDS), the focus is shifting from isolated advances to the ecosystems that enable real-world adoption, where data, policy, infrastructure, and collaboration converge.
The disconnect between ambition and adoption
Momentum is returning to the healthtech sector. According to Galen Growth’s 2024 Digital Health Funding report, global investment rose to $25.1 billion, reversing two years of decline. Europe led this rebound with a 27% year-on-year increase, a sign of renewed confidence in the future of data-enabled healthcare.
Yet despite this influx of capital and a wealth of scientific and technical talent, most innovations still fail to translate into real-world care. 90% of health innovation projects never reach implementation—not because they lack potential, but because they don’t connect with the right people at the right time.
In healthcare, success depends not just on the strength of the idea but on the ability to navigate a fragmented and highly regulated environment. Founders often struggle to access clinical partners or investors. Regulatory pathways vary by country. Hospitals, even when open to innovation, lack the capacity to test new tools. Interoperability remains more aspiration than reality.
The result is a growing disconnect between the scale of investment and adoption. Fewer than 30% of generative AI pilots in healthcare make it into production. Even in well-funded environments, over half of large healthcare organisations report internal resistance to change as a barrier to implementation.
These are not issues of invention. They are failures of connection between innovators and institutions, between potential and practice, and between the ambition to transform care and the structures that enable it.
A European opportunity—and a local vision
The European Health Data Space (EHDS) marks a turning point. By making it easier for patients to access and control their records and for innovators to use anonymised data securely, the EHDS offers a shared framework for accelerating care and research across borders.
But policy alone cannot ensure progress. The real impact of EHDS will depend on whether ecosystems are ready to turn this framework into functioning systems, where data is not just stored, but actively used to generate insight and improve care.
Luxembourg is already laying the groundwork. The country has placed healthtech at the heart of its national innovation strategy, combining infrastructure, research, and coordinated action. It is investing in advanced capabilities like the MeluXina supercomputer (and its future siblings) and federated data environments that ensure privacy and accessibility for research.
Institutions such as the Luxembourg Institute of Health (LIH), the Luxembourg Centre for Systems Biomedicine (LCSB), and initiatives like the HE:AL Campus are helping to translate scientific research into practical solutions. Meanwhile, national initiatives like the AI Factory are shaping the conditions for trustworthy, real-world applications of AI, including in healthcare.
This shift from invention to connection is where forward-looking ecosystems make the difference.
Why ecosystems matter more than ever
Infrastructure provides the foundation, but ecosystems determine what’s built on top of it. Even the most advanced tools and datasets remain underused unless supported by environments designed for collaboration. This is especially true in healthcare, where innovation rarely succeeds in a vacuum.
The most effective ecosystems facilitate meaningful, sustained engagement between all the actors involved: startups, clinical teams, researchers, regulators, providers and investors. They enable access not only to technology but to expertise, decision-making processes, and early testing environments.
With this connective tissue, ideas can move more quickly from lab to clinic, from pilot to policy, and from promise to measurable impact. It is about building a system that supports innovation at the right moment, with the right intensity, and for the right reasons.
At Hive, we believe the next phase of health innovation will be defined not by isolated breakthroughs but by the ability to create strong, strategic connections between people, organisations, and countries. Ecosystems must be active partners in helping innovation navigate complexity, overcome inertia, and deliver results.
Luxembourg provides a compelling model for this approach. It is small enough to be agile, yet embedded in European networks that offer scale. Its public and private sectors are aligned around a shared vision, and its innovation environment is increasingly structured to close the gap between discovery and deployment.
In this way, the country reflects what we believe is the real differentiator in health innovation going forward: not who can invent the most, but who can connect the most effectively—across silos, borders, and disciplines.
The future of healthcare won’t be shaped by individual actors, but by ecosystems designed to work together and built to deliver lasting impact.
Key Figures:
$25.1 billion
Global digital health investment in 2024 (Galen Growth), reversing two years of decline.
+27%
Year-on-year increase in European digital health investment — the highest regional growth worldwide.
90%
Proportion of health innovation projects that never reach real-world implementation.
<30%
Share of generative AI pilots in healthcare that reach production use.
>50%
Percentage of large healthcare organisations citing internal resistance to change as a barrier to adopting innovation.
This article was published in the Silicon Luxembourg magazine.
